Proteomics renews ISO 13485 and ISO 17025 accreditations
Filed with ASX · · 2 pages · English
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to announce that the National Association of Testing Authorities (NATA) of Australia has approved the continuation of the Company’s ISO 17025 accreditation, and the British Standards Institution (BSI) has renewed the Company's ISO 13485 certification. Both renewals will benefit the upcoming global product lau
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- New endometriosis test presented at international conference
- PromarkerD application for Australian MBS to be resubmitted
- Distribution agreement for PromarkerD in Britain extended
- December 2022 Quarterly Activities Report and Appendix 4C
- Letter of intent with Sonic Healthcare USA extended
Later from Proteomics International Laboratories
- March 2023 Quarterly Activities Report and Appendix 4C
- Canagliflozin lowers PromarkerD DKD risk prediction scores
- World Endometriosis Congress - New diagnostic test showcased
- Sonic Healthcare USA signs licence for PromarkerD in the US
- June 2023 Quarterly Activities Report and Appendix 4C
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories